J. P. Sahoo, S. Nath, and K. C. Samal, “Merck’s Oral Antiviral Pill ‘Molnupiravir’: could be a Covid-19 Pandemic Game-Changer”, BioResToday, vol. 3, no. 10, pp. 912–915, Oct. 2021.